LATEST INSIGHTS

HL Pharma shares pharmaceutical news, industry updates and practical guidance for sponsors, healthcare providers and supply partners across Australia.

Managing Unlicensed Medicine Supply in Australia

Managing Unlicensed Medicine Supply in Australia

Accessing medicines that are not registered in Australia involves navigating established TGA regulatory pathways, each with distinct eligibility, documentation and compliance requirements.

read more
1836 912 HL Pharma
Why HL Pharma Joined ARCS Australia
Back of T Shirt with HL Pharma logo

Why HL Pharma Joined ARCS Australia

HL Pharma becomes a Strategic Partner of ARCS Australia, helping us contribute more actively to the conversations shaping access to medicines, clinical supply and patient support across Australia.

read more
1920 1080 HL Pharma
Managing Veterinary Medicine Shortages in Australia
Veterinarian reviewing patient chart in veterinary clinic during medicine supply disruption

Managing Veterinary Medicine Shortages in Australia

Veterinary medicine shortages are impacting oncology, ophthalmology and critical care. Learn how veterinary hospitals can maintain continuity of care through controlled pathways.

read more
753 525 HL Pharma
Solar and Battery: Reducing Energy Use Without Compromising Control
Roof-mounted solar installation at HL Pharma’s Melbourne temperature-controlled pharmaceutical storage facility.

Solar and Battery: Reducing Energy Use Without Compromising Control

HL Pharma has installed on-site solar generation and battery storage at our Melbourne facility as we focus on sustainability to strengthen operational resilience and control.

read more
860 600 HL Pharma
TGA Medicine Shortages in Australia: Practical Continuity Support

TGA Medicine Shortages in Australia: Practical Continuity Support

Medicine shortages are now part of the day-to-day reality for Australian hospitals and pharmacies. When an essential medicine becomes constrained, the impact is immediate.

read more
724 483 HL Pharma
Why Trial and Early Access Medicines Need Specialist APAC Depots
Meeting Sponsor & TGA Expectations: The New Standard for Clinical & MAP/EAP Depots in ANZ

Why Trial and Early Access Medicines Need Specialist APAC Depots

Stricter storage, cold-chain and governance rules mean clinical trial, Managed Access and Early Access medicines now rely on specialist depots across Australia and APAC.

read more
1846 920 HL Pharma
Enter your search term...